About VERIGRAFT
Verigraft is a Swedish biotech company that develops personalized tissue-engineered transplants for medical treatments. They use a special technology to turn donated human tissue into patient-specific grafts. Their main focus is on heart and blood vessel treatments, creating custom veins and arteries to prevent tissue rejection during transplants.
Legal Name
: VERIGRAFT
Headquarters
: , Sweden
Business Model
:
Founding Date
: 1970
No. of Employees
:
Founding Members
Recently Added Startups
UXPin
UXPin’s design editor lets you create the perfect user experience from start to finish without leaving the app
Related Post
VERIGRAFT funding news – Gothenburg-based VERIGRAFT Raises €1.2 Million in Funding
Europe Weekly Startup Funding News Report For Monday, 14 April 2025 to Saturday, 19 April 2025
February 2025 Funding Recap
Biotech
Astraveus
They build high tech equipment supporting end-to-end development and manufacture of cell and gene therapies.
Novartis
Rethink medicine to help people live longer and healthier lives, giving patients, doctors, and communities the tools they need to face serious illnesses with confidence.
